Judith M. Roesink

Utrecht, UT 3508GA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Long-term prognostic value of staging surgery for high-intermediate-risk and high-risk endometrial cancer.

Long-term prognostic value of staging surgery for high-intermediate-risk and high-risk endometrial cancer.

Journal: Journal of robotic surgery

Published: January 13, 2026

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Journal: Journal of the National Cancer Institute

Published: September 12, 2025

Predicting long-term absolute risk of lung cancer in patients with Hodgkin lymphoma.

Predicting long-term absolute risk of lung cancer in patients with Hodgkin lymphoma.

Journal: Journal of the National Cancer Institute

Published: September 12, 2025

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.

Journal: Journal of the National Cancer Institute

Published: September 08, 2025

Adaptive brachytherapy for cervical cancer in combined 1.5 T MR/HDR suite: Impact of repeated imaging.

Adaptive brachytherapy for cervical cancer in combined 1.5 T MR/HDR suite: Impact of repeated imaging.

Journal: Technical innovations & patient support in radiation oncology

Published: April 25, 2024

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma.

Journal: ESMO open

Published: October 13, 2023

Risk of male breast cancer after Hodgkin lymphoma.

Risk of male breast cancer after Hodgkin lymphoma.

Journal: Blood

Published: April 25, 2023

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.

Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.

Journal: JAMA oncology

Published: February 02, 2023

In Regard to Dennstädt et al.

In Regard to Dennstädt et al.

Journal: International journal of radiation oncology, biology, physics

Published: October 18, 2022

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.

Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: January 06, 2022

Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.

Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.

Journal: Cancer

Published: December 04, 2021

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.

Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.

Journal: Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society

Published: February 05, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026